Table 2 Summary of primary tumor stage and location.
From: Metallopanstimulin as a marker for head and neck cancer
Primary | Stage | Â | Â | |||
|---|---|---|---|---|---|---|
Tumor Site | I | II | III | IV | Total | Percent |
Hypopharynx | 0 | 1 | 0 | 1 | 2 | 1.6% |
Larynx | 7 | 4 | 18 | 18 | 47 | 37.6% |
Nasopharynx | 0 | 0 | 0 | 4 | 4 | 3.2% |
Neck | 0 | 1 | 1 | 3 | 5 | 4.0% |
Oral Cavity | 5 | 8 | 4 | 16 | 33 | 26.4% |
Oropharynx | 0 | 0 | 2 | 18 | 20 | 16.0% |
Parotid | 0 | 0 | 2 | 0 | 2 | 1.6% |
Skin | 4 | 2 | 3 | 3 | 12 | 9.6% |
Total | 16 | 16 | 30 | 63 | 125 | Â |
Percent | 12.8% | 12.8% | 24.0% | 50.4% | 100.0% | Â |